At least two independent reports on the treatment of VN (voretigene neparvovec) for RPE65-LCA2 has identified retinal atrophic changes on fundus autofluorescence images, following sub-retinal… Read More »Real-word data from voretigene neparvovec treatment of RPE65-LCA2 reports retinal atrophy in Germany and US studies.
A research team based at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, have reported a new NEI VFQ-25C aimed at calibrating a… Read More »A new NEI VFQ-25C has reported valuable changes to enable comparison of patient-reported outcome measures.
Researchers based at the Buck Institute for Research on Aging, in San Francisco, California, have reported results on the impact of dietary restriction, circadian rhythms… Read More »Research on dietary restriction and the molecular circadian rhythm aims to assess eye health and lifespan
Researchers based at the John A. Moran Eye Centre, University of Utah, Salt Lake City, USA, have reported a significant study on the viability of… Read More »Light signalling in the post-mortem mouse and human retina may show significant implications on ophthalmic conditions and brain sciences.
Researches based in the Centre for Ophthalmology, Eberhard Karls University of Tübingen, Germany, has reported the natural course of disease progression, with respect to central… Read More »Genotype-Phenotype correlations in PDE6A associated with arRP shows the range of severity
Researches based in Canada, UK, Singapore and the USA has reported a comprehensive systematic review and meta analyses on the comparison of anti-VEGF regimens to… Read More »A systematic review and meta-analyses study has reported the efficacy, safety, and treatment burden of T&E, versus alternative anti-VEGF regimens for nAMD
A publication in Science (Nurket et al., Vol. 376,44–53, April 1, 2022), has presented a complete sequence of a human genome, led by a consortium… Read More »The genomic “Telomere-to-Telomere” (T2T) consortium has published a gap-free human genome sequence in Science
Foundation Fighting Blindness (FFB) are to invite a “Patient-Focused Drug Development” meeting, in the coming months, with Food and Drug Administration (FDA) representatives. The objective… Read More »X-linked Retinitis pigmentosa (XLRP) participants are invited to “My Retina Tracker Registry”, supported by Foundation Fighting Blindness
Researchers at the Instituto de Investigación Sanitaria–Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, has reported valuable clinical re-classifications from inherited dystrophies following next-generation… Read More »Next-generation sequencing data on inherited macular dystrophies (MD) shows significant impact among 1,036 Spanish families
Researchers at the Universidad de Oviedo, Spain, has reported a systematic review and analysis on stem cell treatments for a range of retinal degenerative disease. … Read More »A systematic review on human stem cell transplantation treatments for retinal degenerative diseases has provided significant promise on the horizon.